Tuesday, February 19, 2013
A meeting has been set for March 6th in Washington, D.C. between officials involved in Food and Drug Administration (FDA) oversight of clinical trials and Tisch MS Research Center senior staff. This is a long-awaited meeting and through it we hope to obtain guidance on how to proceed with our proposal for a clinical trial of stem cells in the treatment of multiple sclerosis. A further update will be provided in this space after March 6th.
Tisch MS Research Center of New York
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.